Global Apheresis Machines Market Size By Type (Donor Apheresis, Therapeutic Apheresis), By Application (Hospitals, Blood Center), By Region, And Segment Forecasts, 2023 to 2032

The Global Apheresis Machines Market was valued at USD 2.4 billion in 2023 and is projected to surpass USD 4.8 billion by 2031, growing at a CAGR of 9.1% during the forecast period from 2023 to 2031. Apheresis machines are increasingly used in the treatment of blood-related disorders and for the collection of specific blood components such as plasma, platelets, and leukocytes. The market is witnessing strong growth due to the rising prevalence of chronic and autoimmune diseases, advancements in apheresis technologies, and increasing demand for blood components in therapeutic applications.

Drivers:

Rising Prevalence of Chronic Diseases:

Chronic illnesses like leukemia, autoimmune disorders, and cardiovascular diseases are increasing globally. Apheresis therapy is a critical component of treatment in many such conditions, driving the demand for advanced and efficient machines.

Technological Advancements in Apheresis Devices:

New-generation apheresis systems offer features such as automation, improved safety, shorter treatment times, and higher yield efficiency, which significantly enhance the procedure's effectiveness and patient comfort.

Growing Use in Organ Transplantation and Cancer Treatment:

The demand for apheresis is increasing in organ transplantation and oncology, where specific blood component collection or therapeutic exchange is required, further boosting market expansion.

Restraints:

High Cost of Equipment and Procedures:

Advanced apheresis machines and the procedures involved remain expensive, limiting their adoption in low-income regions or small healthcare facilities.

Lack of Trained Healthcare Professionals:

Operating apheresis systems requires skilled technicians and clinicians. A shortage of such professionals in developing countries may hinder market growth.

Opportunity:

Emerging Markets and Healthcare Infrastructure Expansion:

Rapid improvements in healthcare access in Asia-Pacific, Latin America, and Africa present a huge growth potential for apheresis machines, especially as awareness of therapeutic apheresis expands.

Increasing Blood Component Demand for Clinical Applications:

As personalized medicine and cell-based therapies grow, so does the need for precise and efficient blood component separation, creating a favorable market environment.

Market by System Type Insights:

In 2023, Centrifugal Apheresis Machines dominated the market due to their widespread use in hospitals and blood donation centers. These machines offer faster processing and higher yield, making them ideal for platelet and plasma collection. Membrane Separation Machines are expected to gain significant traction during the forecast period owing to their efficiency in plasma exchange and lower anticoagulant requirements.

Market by End-use Insights:

The Hospitals & Blood Centers segment held the largest market share in 2023, driven by the increasing number of blood transfusion procedures and therapeutic treatments conducted in clinical settings. Meanwhile, Research Institutions & Biopharmaceutical Companies are projected to register the fastest growth due to rising investments in cellular therapy and clinical trials.

Market by Regional Insights:

North America led the market in 2023, supported by advanced healthcare infrastructure, high awareness levels, and the strong presence of leading manufacturers. Asia-Pacific is expected to grow at the highest CAGR due to expanding healthcare access, rising chronic disease incidence, and government support for blood donation and transfusion programs in countries like India and China.

Competitive Scenario:

Major players in the Global Apheresis Machines Market include Haemonetics Corporation, Fresenius Kabi, Terumo BCT, Asahi Kasei Medical Co., Ltd., B. Braun Melsungen AG, Nikkiso Co., Ltd., and Kaneka Corporation. These companies are actively engaging in new product development, geographical expansion, and strategic collaborations to strengthen their global footprint.

Key Market Developments:

2023: Haemonetics launched a next-gen automated apheresis platform designed to improve operational efficiency and reduce donor procedure times.

2024: Fresenius Kabi announced a strategic collaboration with a European healthcare provider to implement its integrated apheresis solutions in over 50 hospitals.

2025: Terumo BCT expanded its manufacturing plant in Asia-Pacific to cater to increasing regional demand for therapeutic apheresis machines.

Scope of Work – Global Apheresis Machines Market

Report Metric Details

Market Size (2023) USD 2.4 billion

Projected Market Size (2031) USD 4.8 billion

CAGR (2023–2031) 9.1%

Market Segments By System Type (Centrifugal, Membrane), By End-use

Growth Drivers Chronic disease prevalence, technological innovation

Opportunities Emerging markets, demand for therapeutic applications

FAQs

1) What is the current market size of the Global Apheresis Machines Market?

The market size in 2023 is valued at USD 2.4 billion.

2) What is the major growth driver of the Global Apheresis Machines Market?

The major driver is the rising prevalence of chronic diseases and the growing use of apheresis in therapeutic and diagnostic applications.

3) Which is the largest region during the forecast period in the Global Apheresis Machines Market?

North America is expected to remain the largest regional market during the forecast period.

4) Which segment accounted for the largest market share in the Global Apheresis Machines Market?

The Hospitals & Blood Centers segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Apheresis Machines Market?